Status:
COMPLETED
Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Vasculopathy
Allograft
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Primary purpose :To early detect cardiac allograft vasculopathy and to identify patients with high risk of cardiac events, by coupling the analysis of the kinetics of the brain natriuretic peptide ( B...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Heart transplant recipients
- Exclusion criteria:
- No respect of inclusion criteria
- Pregnancy
- Severe renal failure (creatinin clearance \< or equal to 30 ml/min)
- Dobutamine stress echocardiography contraindication
Exclusion
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2016
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00384540
Start Date
September 1 2006
End Date
December 20 2016
Last Update
July 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Physiologie et d'Explorations Fonctionnelles, Hôpital Civil, Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091